Home > Journals > Minerva Ophthalmology > Past Issues > Minerva Oftalmologica 2012 June;54(2) > Minerva Oftalmologica 2012 June;54(2):69-73

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Share

 

REVIEWS   

Minerva Oftalmologica 2012 June;54(2):69-73

Copyright © 2012 EDIZIONI MINERVA MEDICA

language: Italian

The compliance role in glaucoma therapy

Actis A. G., Penna R., Brogliatti B., Rolle T.

Sezione di Oftalmologia, Clinica Oculistica, Dipartimento di Fisiopatologia Clinica, Università degli Studi di Torino, Torino, Italia


PDF


The number of studies that investigate compliance in glaucoma is consistent and has increased dramatically in recent years, confirming the growing interest in this topic. The available literature data show how often antiglaucomatous therapy is managed by the patient in a suboptimal way: adherence is therefore a common problem for many glaucoma patients, especially for those newly diagnosed. In our review we analyze this issue with particular reference to risk factors associated with poor compliance: they are still often poorly defined and understood, and while some of them reach unanimous agreement in the literature, others seem to play a controversial role. The problem, which recognizes a multifactorial genesis, requires a personalized approach based on the characteristics of each patient.

top of page